Safety and Immunogenicity of Hiv Recombinant Envelope Vaccines in Hiv-Infected Infants and Children. † 57

Pediatric Research - United States
doi 10.1203/00006450-199604001-00076
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Safety of Darunavir and Atazanavir in HIV-infected Children in Europe and Thailand

Antiviral Therapy
Infectious DiseasesPharmacology
2015English

Early HIV-1 Envelope-Specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants

Journal of Experimental Medicine
MedicineAllergyImmunology
1997English

HIV and cART-Associated Dyslipidemia Among HIV-Infected Children

Journal of Clinical Medicine
2019English

Safety, Tolerability, and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV-Infected Patients Receiving Combination Antiretroviral Therapy

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2013English

Raltegravir for HIV-1 Infected Children and Adolescents: Efficacy, Safety, and Pharmacokinetics

Adolescent Health, Medicine and Therapeutics
2013English

Neurodevelopment, Growth, and Viral Load in HIV-Infected Infants

Brain, Behavior, and Immunity
EndocrineImmunologyBehavioral NeuroscienceAutonomic Systems
1996English

Safety and Immunogenicity of Novel Recombinant BCG and Modified Vaccinia Virus Ankara Vaccines in Neonate Rhesus Macaques

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2010English

Immunologic Abnormalities in HIV-infected Children

Jornal de Pediatria
Child HealthPediatricsPerinatology
1999English

Long-Term Safety and Effectiveness of Lopinavir/Ritonavir in Antiretroviral-Experienced HIV-1-infected Children

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy